EB1 Gene and Colorectal Cancer
Author Information
Author(s): P Jais, J-C Sabourin, J Bombled, P Rougier, P Lasser, P Duvillard, J Benard, B Bressac-de Paillerets
Primary Institution: Institut Gustave Roussy
Hypothesis
The interaction between APC and EB1 proteins may be important for the tumour-suppressor activity of APC protein, and raises the hypothesis that EB1 is also involved in sporadic colorectal tumorigenesis.
Conclusion
The present findings strongly suggest that EB1 gene is not involved in somatic colorectal carcinogenesis.
Supporting Evidence
- None of the tumors contained somatic mutation.
- A silent cDNA variant was identified in 14% of alleles.
- Only one out of 28 colorectal tumors contained a loss of heterozygosity at the D20S107 marker.
Takeaway
Scientists looked at a gene called EB1 in people with colorectal cancer and found that it doesn't change in a way that would cause cancer.
Methodology
Somatic mutations in the entire coding sequence of EB1 cDNA were searched by reverse transcriptase single-strand conformational polymorphism (SSCP) analysis in 21 sporadic colorectal cancers and seven adenomas.
Limitations
The study did not search for APC mutations in the analyzed tumors.
Participant Demographics
21 patients (11 males and 10 females) with a mean age of 67.5 years.
Want to read the original?
Access the complete publication on the publisher's website